SOLICITATION NOTICE
U -- Medical Biochemical Genetics Fellowship Training
- Notice Date
- 4/24/2014
- Notice Type
- Presolicitation
- NAICS
- 611430
— Professional and Management Development Training
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Heart, Lung and Blood Institute, Rockledge Dr. Bethesda, MD, Office of Acquisitions, 6701 Rockledge Dr RKL2/6100 MSC 7902, Bethesda, Maryland, 20892-7902
- ZIP Code
- 20892-7902
- Solicitation Number
- HHS-NIH-NHLBI-CSB-(HG)-2014-117-DLM
- Archive Date
- 5/17/2014
- Point of Contact
- Dorothy Maxwell, Phone: 301-435-0352
- E-Mail Address
-
maxwelld@mail.nih.gov
(maxwelld@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- THIS IS A NOTICE OF INTENT, NOT A REQUEST FOR A PROPOSAL. A SOLICITATION DOCUMENT WILL NOT BE ISSUED AND PROPOSALS WILL NOT BE REQUESTED. The National Heart, Lung, and Blood Institute (NHLBI) Office of Acquisition (OA) intends to negotiate and award a purchase order on a non-competitive sole source basis to Clinic for Special Children, 535 Bunker Hill Road, P.O. Box 128, Strasburg, Pennsylvania 17579 to provide rotations for medical biochemical genetics fellowship training. Period of Performance Base with two option year periods : Base Year: June 2014 through May 2015 Option Year 1: June 2015 through May 2016 Option Year 2: June 2016 through May 2017 Background: The National Institutes of Health (NIH) mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability. The National Human Genome Research Institute (NHGRI), Division of Intramural Research (DIR) was established to serve as a hub where development of technology for the rapid isolation and analysis of disease genes will be carried out. The DIR's basic research laboratories and clinical branches develop and use the most advanced techniques to conduct research in medical genetics. Research includes identifying and understanding the molecular basis of human genetic disease and planning and carrying out clinical trials to test methods for the treatment. The National Human Genome Research Institute (NHGRI), mission has expanded to encompass a broad range of studies aimed at understanding the structure and function of the human genome and its role in health and disease. NHGRI supports the development of resources and technology that will accelerate genome research and its application to human health. A critical part of the NHGRI mission continues to be the study of the ethical, legal and social implications (ELSI) of genome research. NHGRI also supports the training of investigators and the dissemination of genome information to the public and to health professionals. The National Human Genome Research Institute (NHGRI), Division of Intramural Research (DIR), overall mission is to develop and implement technology for the rapid isolation, analysis, and treatment of genetic diseases. The Division's research laboratories and clinical branches develop and use the most advanced techniques to study the fundamental mechanisms of inherited and acquired genetic disorders. Research also includes planning and conducting clinical trials to test DNA-based methods for treatment and perhaps the cure of such diseases. Researchers collect and study families in which important diseases are inherited as well as, translate basic science advances into effective, reliable, and cost effective DNA and cytogenetic-based diagnostics. The mission of the DIR includes the training of physicians and doctoral degree fellows in medical genetics through the Medical Genetics and Genomic Medicine Residency and Fellowship Training Programs. The Training Program are administered by the Office of the Clinical Director (OCD) and is accredited by the American Board of Medical Genetics (AMBG). The purpose of this contract is to maintain formal training program sites for the instruction of medical and doctoral fellows as part of the requirements for board certification in Clinical Genetics, Medical Biochemical Genetics, Clinical Biochemical Genetics, Clinical Molecular Genetics and Clinical Cytogenetics. Purpose : The Requirements for board certification of competency of our trainees include broad exposure to and experience with pediatric and adult genetic disorders, including metabolic and mitochondrial disorders, complex traits, skeletal dysplasias, clefting, phacomatoses, and chromosomal disorders. The training must include information on the diagnosis and management of these disorders, including the opportunity to rotate in CLIA approved diagnostic genetic laboratories run by American Board of Medical Genetics (ABMG) certified staff. Another component must be the follow up of abnormal newborn screening results. To meet these requirements the Medical Genetics Branch and OCD seek nearby institutions to provide these components of training for board certification in Clinical Genetics, Clinical Biochemical Genetics, Medical Biochemical Genetics, Clinical Molecular Genetics and Clinical Cytogenetics. The staff, which must include both ABMG board certified geneticist(s) and a genetic counselor, will be required to train fellows in the approach, diagnosis and management of various genetic disorders. In addition, trainees need to have training in applicable laboratory techniques and the clinical interpretation and implications of the test results. The staff must also participate in the comprehensive teaching of fellows; including participation in lecture series, journal clubs, and case conferences. A genetic counselor will assist in the training of fellows in the interpretation and genetic implication of tests they are learning to perform in these diagnostic laboratories. Objectives: The goals of the program are to : 1. Provide a training facility that will conduct one-month training experiences in clinical genetics for M.D. trainees seeking certification in Medical Biochemical Genetics. 2. To provide a genetic counselor to assist in the training of the fellows in the genetic counseling implications of the diagnoses that have been made. 3. To participate in the comprehensive training of all trainees in genetics as part of the Molecular Genetics and Genomic Medicine and Medical Biochemical Genetics Fellowship programs by hosting a 1 day seminar in the fall. Specific tasks to be performed are : 1. Each year the training program will enroll up to four (4) medical biochemical fellows. Two fellows per year can spend one (1) month at the Clinic for Special Children. 2. Track the progress of each fellow to insure that they will have had necessary experiences for AMGB certification. Industry Classification (NAICS) Code is 611710, Educational Support Services, small business size standard is $14.0M. The acquisition is being conducted under FAR Part 13, simplified acquisition procedures, therefore the requirements of FAR Part 6 B Competitive Requirements are not applicable (FAR Part 6.001). The resultant Contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 05-72 (January 30, 2014). This requirement is under the SAT of $150,000.00. This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov." A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by May 2, 2014 and must reference synopsis number HHS-NIH-NHLBI-CSB-(HG)-2014-117-DLM, may be submitted to the National, Heart, Lung and Blood Institute, Office of Acquisition, COAC Services Branch, 6701 Rockledge Drive, Suite 6149, Bethesda, Maryland 20892-7902, Attention: Dorothy Maxwell. Response may be submitted electronically to maxwelld@mail.nih.gov. Faxes will not be accepted. Responses will only be accepted if dated and signed by an authorized company representative. "All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency."
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NHLBI/HHS-NIH-NHLBI-CSB-(HG)-2014-117-DLM/listing.html)
- Place of Performance
- Address: Contractor's Location/NIH, United States
- Record
- SN03347935-W 20140426/140424235114-53a368e25a74800257faea0410dd9c3c (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |